Publicacións nas que colabora con Juan Luis Steegmann Olmedillas (4)

2003

  1. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses

    Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758

1996

  1. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)

    American Journal of Hematology, Vol. 53, Núm. 3, pp. 169-174

1995

  1. Hypertriglyceridemia may be severe in CML patients treated with interferon‐α

    American Journal of Hematology, Vol. 49, Núm. 3, pp. 240-241

  2. TRASPLANTE ALOGENICO DE MEDULO OSEA EN LA LEUCEMIA MIELOIDE CRONICA. RESULTADOS CLINICOS Y FACTORES DE RIESGO EN 70 PACIENTES

    Medicina Clinica, Vol. 105, Núm. 16, pp. 605-611